Quantcast
Tag archive for ‘tedizolid’
By The Dispatch On Monday, March 31st, 2014
2 Comments

Sivextro, to treat MRSA skin infections, receives recommendation from FDA Anti-Infective Drugs Advisory Committee

PRESS RELEASE Cubist Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) Anti-Infective Drugs Advisory Committee (AIDAC) voted to recommend approval of Cubist’s investigational More...

By The Dispatch On Monday, December 30th, 2013
0 Comments

FDA accepts Cubist’s NDA for the investigational antibiotic tedizolid to treat MRSA infections

PRESS RELEASE  Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for its investigational antibiotic tedizolid More...


Recent Posts


DISPATCH BLOGS

Splash Page logo 300x146 Today in History